Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 10, 2009 12:59 ET | Source: Avigen, Inc.

Avigen Reports Second Quarter 2009 Financial Results

ALAMEDA, Calif., Aug. 10, 2009 (GLOBE NEWSWIRE) -- Avigen, Inc. (Nasdaq:AVGN) a biopharmaceutical company, today reported financial results for its second quarter ended June 30, 2009. At June 30,...
May 20, 2009 08:00 ET | Source: Avigen, Inc.

Avigen Granted AV411 Patent for Neuropathic Pain

ALAMEDA, Calif., May 20, 2009 (GLOBE NEWSWIRE) -- Avigen, Inc. (Nasdaq:AVGN) a biopharmaceutical company, announced today that it has been granted United States Patent No. 7,534,806, entitled "Method...
May 11, 2009 08:00 ET | Source: Avigen, Inc.

Avigen Reports First Quarter 2009 Financial Results

ALAMEDA, Calif., May 11, 2009 (GLOBE NEWSWIRE) -- Avigen, Inc. (Nasdaq:AVGN) a biopharmaceutical company, today reported financial results for its first quarter ended March 31, 2009. At March 31,...
March 31, 2009 08:00 ET | Source: Avigen, Inc.

Avigen's Stockholders Deny BVF's Bid to Remove Board of Directors in Proxy Fight

ALAMEDA, Calif., March 31, 2009 (GLOBE NEWSWIRE) -- Avigen, Inc. (Nasdaq:AVGN), a biopharmaceutical company, today announced that based on the final tabulation of votes reported by the independent...
March 26, 2009 09:21 ET | Source: Avigen, Inc.

Avigen Board Discontinues Strategic Merger Discussions to Develop a Plan for Liquidation

ALAMEDA, Calif., March 26, 2009 (GLOBE NEWSWIRE) -- Avigen, Inc. (Nasdaq:AVGN), a biopharmaceutical company, today announced that its Board of Directors has discontinued its strategic merger...
March 18, 2009 14:40 ET | Source: Avigen, Inc.

Leading Independent Advisory Service Urges Avigen Stockholders to Reject BVF's Proposal

ALAMEDA, Calif., March 18, 2009 (GLOBE NEWSWIRE) -- Avigen, Inc. (Nasdaq:AVGN), a biopharmaceutical company, today announced that its Board of Directors issued the following comments in a letter to...
March 11, 2009 08:00 ET | Source: Avigen, Inc.

Avigen's Board Urges Stockholders to Reject BVF's Proposal

ALAMEDA, Calif., March 11, 2009 (GLOBE NEWSWIRE) -- Avigen, Inc. (Nasdaq:AVGN), a biopharmaceutical company, today announced that it has scheduled a Special Meeting of Stockholders as requested by...
February 25, 2009 08:00 ET | Source: Avigen, Inc.

Avigen Announces Positive Data for AV411 in Pain Relief and Drug Addiction

ALAMEDA, Calif., Feb. 25, 2009 (GLOBE NEWSWIRE) -- Avigen, Inc. (Nasdaq:AVGN), a biopharmaceutical company, announced today that two preclinical reports with glial attenuator AV411 (ibudilast) support...
February 11, 2009 08:00 ET | Source: Avigen, Inc.

Avigen Reports 2008 Financial Results and Updates Progress On Strategic Review

ALAMEDA, Calif., Feb. 11, 2009 (GLOBE NEWSWIRE) -- Avigen, Inc. (Nasdaq:AVGN), a biopharmaceutical company, today reported financial results for its fourth quarter and year ended December 31, 2008. At...
February 06, 2009 08:00 ET | Source: Avigen, Inc.

Avigen Board Rejects BVF Offer as Inadequate

Recommends Stockholders Not Tender Shares Company Reviewing Strategic Alternatives ALAMEDA, Calif., Feb. 6, 2009 (GLOBE NEWSWIRE) -- Avigen, Inc. (Nasdaq:AVGN), a...